Scigalla Paul 4
4 · GENELUX Corp · Filed Oct 21, 2024
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Scigalla Paul
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-10-18+16,666→ 16,666 totalExercise: $6.00Exp: 2034-10-17→ Common Stock (16,666 underlying) - Award
Stock Option (right to buy)
2024-10-18+16,666→ 16,666 totalExercise: $6.00Exp: 2034-10-17→ Common Stock (16,666 underlying)
Footnotes (2)
- [F1]Immediately exercisable.
- [F2]100% of the shares subject to the Option shall vest on December 31, 2024.